Search Within

Anthony Yu

Formats
  1. Journal Article (49)
  2. Meeting Abstract (33)
  3. Review (5)
  4. Book Section (3)
  5. Editorial (3)
  6. Guidelines (1)
  7. Research Letter (1)
Groups
  1. Cardiology (95)
  2. Department of Medicine (95)
  3. Division of Subspecialty Medicine (95)
  4. Population Sciences Research Program (95)
  5. Survivorship Research (95)
  6. Solid Tumor Oncology Division (62)

More Groups

People
  1. Chau Dang (46)
  2. Richard Steingart (46)
  3. Jennifer Liu (45)
  4. Lee Jones (20)
  5. Chaya Moskowitz (17)
  6. Clifford Hudis (13)

More People

Years
  1. 2025 (8)
  2. 2024 (7)
  3. 2023 (9)
  4. 2022 (5)
  5. 2021 (9)
  6. 2020 (12)

More Years

Publications
  1. Journal of the American College of Cardiology (14)
  2. Journal of Clinical Oncology (13)
  3. Breast Cancer Research and Treatment (5)
  4. JACC: CardioOncology (5)
  5. The Oncologist (5)
  6. Cancer Research (3)

More Publications

Publishers
  1. Elsevier Science, Inc. (14)
  2. American Society of Clinical Oncology (13)
  3. Elsevier Inc. (11)
  4. Oxford University Press (10)
  5. Springer (8)
  6. American College of Cardiology (5)

More Publishers

Results (95)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Effects of non-linear or linear aerobic training (AT) dosing regimens on impaired cardiovascular (CV) function in patients with operable breast cancer: A randomized controlled trial (RCT)
    Meeting Abstract

    Scott, J.; Thomas, S. M.; Herndon, J. E.; Peppercorn, J. M.; Douglas, P. S.; Khouri, M.; Dang, C. T.; Yu, A. F.; Catalina, D.; Ciolino, C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Assessing cardiac safety in oncology drug development
    Review

    Seltzer, J. H.; Gintant, G.; Amiri-Kordestani, L.; Singer, J.; Pesco Koplowitz, L.; Moslehi, J. J.; Barac, A.; Yu, A. F.
    American Heart Journal (2019)

    Fulltext@MSK | Save
  • Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: The SAFE-HEaRt study
    Journal Article

    Lynce, F.; Barac, A.; Geng, X.; Dang, C.; Yu, A. F.; Smith, K. L.; Gallagher, C.; Pohlmann, P. R.; Nunes, R.; Herbolsheimer, P.; more...
    Breast Cancer Research and Treatment (2019)

    Fulltext@MSK | Save
  • Cardiotoxicity of HER2-targeted therapies
    Review

    Copeland-Halperin, R. S.; Liu, J. E.; Yu, A. F.
    Current Opinion in Cardiology (2019)

    Fulltext@MSK | Save
  • Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced left ventricular ejection fraction
    Journal Article

    Hussain, Y.; Drill, E.; Dang, C. T.; Liu, J. E.; Steingart, R. M.; Yu, A. F.
    Breast Cancer Research and Treatment (2019)

    Fulltext@MSK | Save
  • Cardiotoxicity of contemporary breast cancer treatments
    Review

    Lee Chuy, K.; Yu, A. F.
    Current Treatment Options in Oncology (2019)

    Fulltext@MSK | Save
  • Assessment of early radiation-induced changes in left ventricular function by myocardial strain imaging after breast radiation therapy
    Journal Article

    Yu, A. F.; Ho, A. Y.; Braunstein, L. Z.; Thor, M. E.; Lee Chuy, K.; Eaton, A.; Mara, E.; Cahlon, O.; Dang, C. T.; Oeffinger, K. C.; more...
    Journal of the American Society of Echocardiography (2019)

    Fulltext@MSK | Save
  • Long-term impairment of cardiorespiratory fitness and left ventricular systolic function after trastuzumab cardiotoxicity in HER2-positive breast cancer survivors
    Meeting Abstract

    Yu, A. F.; Jones, L.; Dang, C.; Steingart, R.; Liu, J.
    Journal of the American College of Cardiology (2019)

    Fulltext@MSK | Save
  • Optimal management of adverse events from copanlisib in the treatment of patients with non-Hodgkin lymphomas
    Guidelines

    Cheson, B. D.; O'Brien, S.; Ewer, M. S.; Goncalves, M. D.; Farooki, A.; Lenz, G.; Yu, A.; Fisher, R. I.; Zinzani, P. L.; Dreyling, M.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Cardiac magnetic resonance and cardio-oncology: Does T(2) signal the end of anthracycline cardiotoxicity?
    Editorial

    Yu, A. F.; Chan, A. T.; Steingart, R. M.
    Journal of the American College of Cardiology (2019)

    Fulltext@MSK | Save